Yahoo Web Search

Search results

      • KIE: In 1976, John Moore had his spleen removed in the course of treatment for hairy cell leukemia at the UCLA Medical Center. Subsequently, a cell line was developed from Moore's tissues that offered enormous therapeutic value. Doctors applied for patents on the cell line and entered into contracts for its commercial exploitation.
  1. People also ask

  2. Mosk. Moore v. Regents of the University of California was a landmark Supreme Court of California decision. Filed on July 9, 1990, it dealt with the issue of property rights to one's own cells taken in samples by doctors or researchers.

  3. Oct 13, 2001 · John L. Moore, a leukemia patient who lost a historic property rights battle in which he claimed he deserved to share in the profits from an anti-cancer drug derived from cells taken from his...

  4. In its decision, the Supreme Court of California ruled that cancer patient John L. Moore did not have personal property rights to samples or fluids that his physicians took from his body for research purposes.

  5. [18] The plaintiff is John Moore (Moore), who underwent treatment for hairy-cell leukemia at the Medical Center of the University of California at Los Angeles (UCLA Medical Center).

  6. John Moore sued, claiming an ownership interest in the patent, as well as redress from Dr. Golde for breach of his professional obligations. On appeal, the Supreme Court of California rejected Mr. Moore’s claim to ownership interest in the patent - he was not one of the inventors.

  7. In the case of John Moore's spleen, the most dramatic recasting of the dilemma summoned the threat of enslavement. On both sides of the case, legal experts and cultural observers cautioned that ownership of a human body was the first step on the slippery slope to "bioslavery." The powerful image of a human being defined as chattel and legally owned

  8. Moore v. Regents of the University of California. Facts: Doctors operating on Moore's spleen removed some cancerous cells that later were capable of producing proteins that impacted the immune system. The cells ended up having a tremendous amount of commercial value.